426 related articles for article (PubMed ID: 27232509)
21. Chlorogenic acid decreases retinal vascular hyperpermeability in diabetic rat model.
Shin JY; Sohn J; Park KH
J Korean Med Sci; 2013 Apr; 28(4):608-13. PubMed ID: 23579598
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
[TBL] [Abstract][Full Text] [Related]
23. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Jiang F; Chen Q; Huang L; Wang Y; Zhang Z; Meng X; Liu Y; Mao C; Zheng F; Zhang J; Yan H
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120595
[TBL] [Abstract][Full Text] [Related]
24. Retinal expression of clusterin in the streptozotocin-induced diabetic rat.
Kim YS; Kim YH; Cheon EW; Park JM; Yoo JM; Kang SS; Cho GJ; Choi WS
Brain Res; 2003 Jun; 976(1):53-9. PubMed ID: 12763621
[TBL] [Abstract][Full Text] [Related]
25. Ethanol Extract of Chinese Propolis Attenuates Early Diabetic Retinopathy by Protecting the Blood-Retinal Barrier in Streptozotocin-Induced Diabetic Rats.
Shi YZ; Liu YC; Zheng YF; Chen YF; Si JJ; Chen ML; Shou QY; Zheng HQ; Hu FL
J Food Sci; 2019 Feb; 84(2):358-369. PubMed ID: 30672592
[TBL] [Abstract][Full Text] [Related]
26. Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats.
Paterniti I; Di Paola R; Campolo M; Siracusa R; Cordaro M; Bruschetta G; Tremolada G; Maestroni A; Bandello F; Esposito E; Zerbini G; Cuzzocrea S
Eur J Pharmacol; 2015 Dec; 769():313-23. PubMed ID: 26607470
[TBL] [Abstract][Full Text] [Related]
27. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
28. The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy.
Zhu YN; Zuo GJ; Wang Q; Chen XM; Cheng JK; Zhang S
Int Ophthalmol; 2019 Oct; 39(10):2223-2235. PubMed ID: 30607864
[TBL] [Abstract][Full Text] [Related]
29. Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.
Chen W; Yao X; Zhou C; Zhang Z; Gui G; Lin B
Mediators Inflamm; 2017; 2017():3059763. PubMed ID: 28638179
[TBL] [Abstract][Full Text] [Related]
30. Vaccinium myrtillus extract prevents or delays the onset of diabetes--induced blood-retinal barrier breakdown.
Kim J; Kim CS; Lee YM; Sohn E; Jo K; Kim JS
Int J Food Sci Nutr; 2015 Mar; 66(2):236-42. PubMed ID: 25582181
[TBL] [Abstract][Full Text] [Related]
31. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
33. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
[TBL] [Abstract][Full Text] [Related]
34. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Abdelsaid M; Siddiquei MM; Alam K; Van den Eynde K; De Hertogh G; Opdenakker G; Al-Shabrawey M; Van Damme J; Struyf S
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1956-64. PubMed ID: 25711636
[TBL] [Abstract][Full Text] [Related]
35. Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
Huang CY; Zhou T; Li G; Li MY; Xiong XM; Wu MT; Jiang JL
Amino Acids; 2019 Nov; 51(10-12):1515-1526. PubMed ID: 31576457
[TBL] [Abstract][Full Text] [Related]
36. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
[TBL] [Abstract][Full Text] [Related]
37. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
Yoshida Y; Yamagishi S; Matsui T; Jinnouchi Y; Fukami K; Imaizumi T; Yamakawa R
Diabetes Metab Res Rev; 2009 Oct; 25(7):678-86. PubMed ID: 19685553
[TBL] [Abstract][Full Text] [Related]
38. The effects of Bushen Yiqi Huoxue prescription and its disassembled prescriptions on a diabetic retinopathy model in Sprague Dawley rats.
Xie M; Deng L; Yu Y; Xie X; Zhang M
Biomed Pharmacother; 2021 Jan; 133():110920. PubMed ID: 33232926
[TBL] [Abstract][Full Text] [Related]
39. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
